Daniel Brennan

Mark Massaro

Subhalaxmi Nambi

Tejas Savant

Conor McNamara

William Bonello

Bill Bonello

Conor Noel McNamara

Kyle Boucher

Subbu Nambi

Vidyun Bais

- **SOPHiA GENETICS** and **Myriad Genetics** have formed a strategic collaboration to develop and provide pharmaceutical companies with an innovative **global liquid biopsy companion diagnostic (CDx) test**.  **[1840706_20250923NE80363:0]** 
- This partnership will utilize Myriad's U.S. laboratory capabilities and SOPHiA GENETICS' decentralized network of **over 800 connected institutions in more than 70 countries** for global test deployment.  **[1840706_20250923NE80363:0]** 
- The initial focus will be on the **MSK-ACCESS® powered with SOPHiA DDM™ liquid biopsy application**, with the goal of developing it into a CDx to enhance personalized healthcare.  **[1840706_20250923NE80363:0]** 
- **Myriad** will pursue regulatory submissions in the **U.S.**, while **SOPHiA GENETICS** will manage regulatory submissions **outside of the U.S.**, with both companies collaborating on development.  **[1840706_20250923NE80363:0]**

SOPHiA GENETICS and Myriad Genetics Announce Collaboration for Liquid Biopsy CDx Test

SOPHiA GENETICS (SOPH)